Immunome, Inc. (IMNM)

NASDAQ: IMNM · Real-Time Price · USD

28.75

-0.64 (-2.18%)

At close: Aug 26, 2026, 4:00 PM EDT

28.90

+0.15 (0.52%)

Pre-market: Aug 27, 2026, 7:04 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Development of Targeted Oncology Therapies	6.94M	9.04M	14.02M	-	-
Total	6.94M	9.04M	14.02M	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	6.94M	9.04M	14.02M	-	-
Total	6.94M	9.04M	14.02M	-	-